GSK plc (NYSE: GSK) AI-Powered Stock Analysis
See how GSK plc scores across key metrics like financial growth, valuation, and market position on the NYSE, using AI-driven evaluation.
GSK●NYSE
HealthcareDrug Manufacturers - General
$52.16
$0.80(1.51%)
U.S. Market opens in 1h 35m
GSK plc (NYSE: GSK) AI-Powered Stock Analysis
See how GSK plc scores across key metrics like financial growth, valuation, and market position on the NYSE, using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerGSK plc (NYSE: GSK) Stock Overall Grade
GSK plc's grade for its NYSE listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to GSK plc's overall NYSE stock rating.
Forecast
A+Score
100/100Financial Growth
CScore
40/100Fundamental Growth
A+Score
91/100Key Ratios
AScore
87/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
99/100Analyst Consensus
C+Score
56/100GSK plc (NYSE: GSK) AI-Powered Stock Analysis
On the NYSE, GSK demonstrates Good performance with an overall Forecast Score of 100/100 (A+), reflecting high confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (91/100, A+) highlight its stability, while Key Ratios (87/100, A) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (99/100, A+), the NYSE-listed stock shows competitive strength. Analyst Consensus (56/100, C+) suggests High divergence in outlook.(NYSE: GSK) Component Analysis Explained
Understand the key factors behind each GSK plc (NYSE: GSK) stock grade, including financials, comparisons, and forecasts.